Navigation Links
Gen-Probe Reports Financial Results for the Fourth Quarter of 2011
Date:2/14/2012

SAN DIEGO, Feb. 13, 2012 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) today reported financial results for the fourth quarter of 2011.  Total revenues in the quarter grew 16%, to a new record of $158.2 million, while non-GAAP earnings per share (EPS) increased 18%, to a new high of $0.72.

"Gen-Probe finished 2011 strong, as blood screening sales rebounded in the fourth quarter while clinical diagnostics revenues continued their solid growth," said Carl Hull, the Company's chairman and chief executive officer.  "We enter 2012 with excellent momentum based on several new product launches that are off to good starts."Key financial results for the fourth quarter of 2011 were ($ in millions, except EPS):Non-GAAPGAAP2011

2010

Change2011

2010

ChangeTotal revenues

$158.2

$136.7

+16%$158.2

$136.7

+16%Product sales

$155.2

$131.1

+18%$155.2

$131.1

+18%Operating profit

$45.8

$40.1

+14%$29.4

$36.8

-20%Net income

$33.7

$29.4

+15%$19.9

$27.2

-27%EPS

$0.72

$0.61

+18%$0.42

$0.56

-25%Gen-Probe's GAAP results for the fourth quarter of 2011 were negatively affected by impairment charges of $12.7 million related to acquired goodwill and intangible assets.  

Revenue DetailIn the fourth quarter of 2011, clinical diagnostics product sales grew by 13% compared to the prior year period.  This increase was driven primarily by domestic and international growth of the APTIMA Combo 2® assay for detecting Chlamydia and gonorrhea, and by the inclusion of sales from the former GTI Diagnostics (GTI), which the Company acquired in December of 2010.  Foreign currency fluctuations reduced clinical diagnostics sales by an estimated $0.1 million compare
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Gen-Probe Reports Financial Results for the Second Quarter of 2011
2. Gen-Probe to Webcast Two Upcoming Investor Presentations
3. Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
4. Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2010 Earnings Conference Call
6. Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference
7. Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash
8. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
9. Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
10. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
11. Gen-Probe to Webcast Four Upcoming Investor Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Can economic ... from work motivate members of the public to increase ... including Johns Hopkins Carey Business School Assistant ... yes. Pointing to a large body of recent research ... the May 24, 2013, issue of Science that the ...
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... , May 23, 2013 PuraMed BioScience ... and marketer of over-the-counter (OTC) medicinal and healthcare ... opinion on the company based on low market ... , Non-Prescription, All Natural Product to Treat Migraine ... Outperforms #1 Prescription Competitor , Currently Available ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... Inc., a,privately held biopharmaceutical company developing anti-inflammatory drugs,announced ... 500 patient FRANCIS,(Fewer Recurrent Acute coronary events with ... the impact of,varespladib (A-002) when administered to patients ... event. , "We are ...
... a pioneer in the development of novel products to ... announced that Ted Hibben has joined the company as ... Coley Pharmaceutical Group, where he was most recently vice ... a key role in the company,s $233 million acquisition ...
... Houlihan Smith & Co., Inc.,acted as the exclusive ... Inc. d/b/a NJOY, as announced by Charles Botchway, ... & Company, Inc. The,transaction was led by ... disclosed. , "We appreciate ...
Cached Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3Cequent Names Ted Hibben Chief Business Officer 2Cequent Names Ted Hibben Chief Business Officer 3Houlihan Smith Arranges Non-Control Equity Investment Into Sottera, Inc., dba NJOY, by Miri Pharma, Inc. 2
(Date:5/23/2013)... RICHLAND, Wash. Pacific Northwest National Laboratory honored ... and commercialization of intellectual property at PNNL,s annual ... , The Department of Energy national laboratory ... Year for his work developing battery materials that ... to the electrical grid, and reduce the time ...
(Date:5/23/2013)... per year, carrying more than 284 million tons of cargo, ... dollars in toll fees for the Panama Canal Authority. Each ... of water are used from Gatun Lake, which is also ... in the isthmus. , However, the advent of very ... the ships at sea, has demanded change. The Panama Canal ...
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... have determined that the presence of the rare element ... increase to the consumption of refined platinum, the primary ... cars to reduce smog. A volatile form of osmium ... normal operation of cars, and it gets dispersed globally ...
... Computer engineers at Washington University in St. Louis ... and computing by coupling USB-based ultrasound probe technology ... platform and a medical imaging device that fits ... D. Richard, Ph.D., Washington University Associate Professor of ...
... The bacteria responsible for chronic infections in cystic fibrosis ... surface to start building a structure that helps the ... Scientists have determined that the bacterial cell-surface sugar, ... of the bacterium as a helix, providing a structure ...
Cached Biology News:Increasing levels of rare element found worldwide 2Ultrasound imaging now possible with a smartphone 2Ultrasound imaging now possible with a smartphone 3Sugar on bacteria surface serves as base for a web of resistance 2Sugar on bacteria surface serves as base for a web of resistance 3